Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Exagen (XGN) Deferred Taxes (2020 - 2021)

Exagen filings provide 2 years of Deferred Taxes readings, the most recent being $148000.0 for Q4 2021.

On a quarterly basis, Deferred Taxes rose 1245.45% to $148000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $148000.0, a 239.62% increase, with the full-year FY2022 number at -$306000.0, down 306.76% from a year prior.
Deferred Taxes hit $148000.0 in Q4 2021 for Exagen, up from $11000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $148000.0 in Q4 2021 to a low of -$117000.0 in Q1 2020.